Page last updated: 2024-10-25

cimetidine and Myelodysplastic Syndromes

cimetidine has been researched along with Myelodysplastic Syndromes in 2 studies

Cimetidine: A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output.
cimetidine : A member of the class of guanidines that consists of guanidine carrying a methyl substituent at position 1, a cyano group at position 2 and a 2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl group at position 3. It is a H2-receptor antagonist that inhibits the production of acid in stomach.

Myelodysplastic Syndromes: Clonal hematopoietic stem cell disorders characterized by dysplasia in one or more hematopoietic cell lineages. They predominantly affect patients over 60, are considered preleukemic conditions, and have high probability of transformation into ACUTE MYELOID LEUKEMIA.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Eisenberg, S1
Gurzó, M1
Varga, G1
Dobos, K1
Náfrádi, J1
Petri, A1

Other Studies

2 other studies available for cimetidine and Myelodysplastic Syndromes

ArticleYear
The case of the horrible hives.
    ONS connect, 2011, Volume: 26, Issue:5

    Topics: Cimetidine; Diphenhydramine; Erythrocyte Transfusion; Histamine H1 Antagonists; Histamine H2 Antagon

2011
[Therapeutic possibilities in the management of gastrointestinal bleeding in thrombocytopenic patients].
    Orvosi hetilap, 1994, Apr-10, Volume: 135, Issue:15

    Topics: Aged; Blood Coagulation Disorders; Blood Transfusion; Cimetidine; Ethamsylate; Gastrointestinal Hemo

1994